Sponsored By:

3 Huge Healthcare Trends Can Fatten Your Portfolio

Invest in healthcare trends

      View All  

Treating Diabetes

The major manufacturers of insulin, the main treatment for diabetes, are Novo Nordisk (NVO),Sanofi-Aventis (SNY) and Eli Lilly (LLY). Global sales related to diabetes are a staggering $15.4 billion annually, increasing 400% since 2000.

It is predicted that by 2050, 20% to 30% of the U.S. population will have diabetes, mostly with obese-driven Type 2. United Healthcare estimates that Americans will spend $3.4 trillion over the next 10 years in diabetes-related costs.


Article printed from InvestorPlace Media, http://investorplace.com/2013/11/healthcare-stocks-stocks-to-buy-now-lly-arna/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.